Andrew Ferree's research while affiliated with Boston University and other places

Publications (3)

Article
Full-text available
Cefepime is a fourth generation cephalosporin which is bactericidal for broad spectrum of organisms. This is a case-series of three patients who presented to our hospital with confusion secondary to cefepime use to treat urinary tract infection (UTI) and health care associated pneumonia (HCAP), after excluding other common etiologies of altered men...
Article
Full-text available
Introduction: Parkinson’s disease (PD) is a progressive neurodegenerative disease more common in those over the age of 60. PD is classically characterized by motor features, although patients may also experience non-motor symptoms. Sleep disturbances, such as rapid eye movement (REM) behavior disorder (RBD), are common in patients with PD and may p...
Article
Full-text available
Racial differences in the prevalence of Parkinson’s disease (PD) have been reported for decades. Many of the earliest reports were flawed because they were based on crude datasets, such as hospital databases, death certificates, door-to-door surveys and records of Medicare beneficiaries. These studies provided conflicting results and were found to...

Citations

... Boschung et al. concluded that in the patients with risk factors for developing the CIN, cefepime trough levels should be routinely measured and maintained to be < 7.5 mg/L [6]. The clinical symptoms of CIN include headache (<1%), aphasia (<1%) [7], confusion (<1%), encephalopathy (<1%), seizure (<1%) [8], hallucination (<1%) [2], myoclonus (<1%) [9], status epilepticus (<1%) [10], stupor (<1%) [11], and coma (<1%) [12]. These adverse effects can occur even with the appropriate dosing and usually resolve once the drug is interrupted; however, some patients may require additional interventions (e.g. ...
... Sleep disturbance and vivid dreams were present in about one fifth of our PD patients. This seems lower than other literatures which report the prevalence of sleep disturbance in PD from 65% up to 95% [32]. It can be explained by the fact that we did not apply a laboratory method (polysomnography), so according to our subjective questionnaires, it is possible to miss mild manifestation. ...
... The interviews revealed that the primary barrier for those not linked to a tertiary center was unawareness of research opportunities. The most important barrier for Hispanic PWP and caregivers as well as for other ethnic minorities not linked to a tertiary center may be lack of awareness about research opportunities despite being very interested in research [18,19]. Considering the majority of Hispanic and non-Hispanic PWP agreed that they would be willing to participate if their physician had recommended participation in a study, physicians not informing and providing the importance for PWP and their caregivers about research participation may be among the main reasons for Hispanic underrepresentation in PD research. ...